期刊文献+

扎考必利后处理对离体大鼠心脏的保护作用 被引量:1

The protection of Zacopride postconditioning against the reperfusion injury in rat hearts
下载PDF
导出
摘要 目的观察内向整流钾离子(IK1)通道激活剂扎考必利在缺血后处理中的作用并探讨可能存在的有关机制。方法24只大鼠离体心脏,随机分为非缺血组,缺血再灌组和扎考必利后处理组,分别进行灌注Krebs–Henseleit(K-H)液60min;缺血30 min再灌注K-H液30 min;缺血30 min再灌注含1μmol/L扎考必利的K-H液5 min后改用不含扎考必利的KH液灌注25 min。记录心率(HR),左室发展压(LVDP),左室内压的最大上升下降速率(±dp/dt max)等血流动力学数据,冠脉流速(CF)和心律失常情况。再灌注结束后测量冠脉流出液中的肌钙蛋白I(cTnI),丙二醛(MDA),总超氧化物歧化酶(TSOD)含量,并用2,3,5—氯化三苯基四氮唑(TTC)染色测心梗面积。结果与缺血再灌注组相比,扎考必利后处理组可增加缺血再灌注30 min时的HR,LVDP,+dp/dtmax,CF,减少心律失常的发生并减少cTnI及MDA的生成,增加SOD的活性,减少心梗面积。结论扎考必利后处理可以有效减轻再灌注后心肌损伤,保护心脏收缩功能和减少心律失常的发生。 Objective To observe the effect of zacopride,an inward rectifier potassium (IK1) channel agonist,in the postconditioning against myocardial ischemia reperfusion injury and to explore its mechanisms.Methods 24 isolated lagendorff rat hearts were randomly divided into non-ischemia group (NI group,n =8),ischemia/reperfusion group (IR group,n =8) and zacopride postconditioning group (ZP group,n=8).Krebs-Henseleit (K-H) buffer was perfused for 60 min in NI group.In IR group,after a period of 30 min ischemia,K-H buffer was perfused for 30 min.While in the ZP group,after a period of 30 min ischemia,K-H buffer containing 1 μmol/L zacopride was persued for 5 min,and then a period of 25 min normal K-H buffer perfusion was followed.Hemodynamic data of three groups including the heart rate (HR),left ventricular developed pressure (LVDP),maximum positive and negative derivative of left ventricular pressure (±dp/dtmax) and coronary flow (CF) were recorded.Coronary effluent was collected to measure the concentration of cardiac troponin Ⅰ (cTnⅠ),malondialdehyde (MDA) and total superoxide dismutase (T-SOD).Myocardial infarction size was measured by 2,3,5-triphenyl tetrazolium chloride (TTC) staining.Results Compared with that in the IR group,cardiac hemodynamic data of LVDP,+dp/dtmax and CF in the ZP group was improved significantly.Compared whith that in the other two goups,the incidence of arrhythmia,the generation of cTnⅠ and MDA,and myocardial infarction size reduced significantly,and the SOD activity enhanced apparently in the ZP group.Conclusion Zacopride postconditioning can effectively reduce myocardial injury of ischemia reperfusion by increasing cardiac function and reducing the incidence of arrhythmia.
出处 《中国体外循环杂志》 2014年第2期121-125,共5页 Chinese Journal of Extracorporeal Circulation
关键词 缺血后处理 内向整流钾离子通道 扎考必利 心律失常 Ischemia postconditioning Inward rectifier potassium channel Zacopride Arrhythmia
  • 相关文献

参考文献20

  • 1Zhao ZQ,Corvera JS,Halkos ME,et al.Inhibition of myocardial injury by ischemic postconditioning during reperfusion:comparison with ischemic preconditioning[J].Am J Physiol Heart Circ Physiol,2003,285 (2):H579-588.
  • 2Ovize M,Baxter GF,DiLisa F,et al.Postconditioning and protection from reperfusion injury:where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology[J].Cardiovasc Res,2010,87:406-423.
  • 3Liu QH,Li XL,Xu YW,et al.A novel discovery of IK1 channel agonist:zacopride selectively enhances IK1 current and suppreses triggered arrhythmias in the rat[J].J Cardiovasc Pharmacol,2012,59(1):37-48.
  • 4Wu B,Long C,Hei F,et al.The protective effect of St.Thomas cardioplegia enriched with zacopride on the isolated rat heart[J].Artificial Organs,2013,37(1):E44-50.
  • 5Curtis MJ,Walker MJ.Quantification of arrhythmias using scoring systems:an examination of seven scores in an in vivo model of regional myocardial ischaemia[J].Cardiovasc Res,1988,22(9):656-665.
  • 6Piao L,Li J,McLerie M,et al.Cardiac IK1 underlies early action potential shortening during hypoxia in the mouse heart[J].J Mol Cell Cardiol,2007,43(1):27-38.
  • 7Diaz R J,Zobel C,Cho HC,et al.Selective inhibition of inward rectifier K+ channels (Kir2.1 or Kir2.2) abolishes protection by ischemic preconditioning in rabbit ventricular cardiomyocytes[J].Circ Res,2004,95(3):325-332.
  • 8Fakler B,Brandie U,Glowatzki E,et al.Kit2.1 inward rectifier K+ channels are regulated independently by protein kinases and ATP hydrolysis[J].Neuron,1994,13 (6):1413-1420.
  • 9刘清华,许言午,吴博威.Zacopride增强心肌内向整流钾电流(Ⅰ_(K1))效应的受体和信号转导通路[J].中国病理生理杂志,2012,28(1):6-10. 被引量:4
  • 10Liu QH,Li XL,Xu YW,et al.A novel discovery ofIK1 channel agonist:zacopride selectively enhances IK1 current and suppresses triggered arrhythmias in the rat[J].J Cardiovasc Pharmacol,2012,59(1):37-48.

二级参考文献14

  • 1Talley NJ.5-hydroxytryptamine agonists and antagonists in the modulation of gastro-intestinal motility and sensation:clinical implications[J].Aliment Pharmacol Ther,1992,6(3):273-289.
  • 2Costall B,Naylor RJ.Neuropharmacology of emesis in relation to clinical response[J].Br J Cancer Suppl,1992,19:S2-S7.
  • 3Fakler B,Brndle U,Glowatzki E,et al.Kir2.1 inward rectifier K^+ channels are regulated independently by protein kinases and ATP hydrolysis[J].Neuron,1994,13 (6):1413-1420.
  • 4Koumi S,Wasserstrom JA,Ten Eick RE.β-Adrenergic and cholinergic modulation of inward rectifier K+ channel function and phosphorylation in guinea-pig ventricle[J].J Physiol,1995,486(Pt 3):661-678.
  • 5Kiesecker C,Zitron E,Scherer D,et al.Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1[J].J Mol Med,2006,84(1):46-56.
  • 6De Ponti F.Pharmacology of serotonin:what a clinician should know[J].Gut,2004,53(1):1520-1535.
  • 7Thompson AJ,Lummis SC.The 5-HT3 receptor as a therapeutic target[J].Expert Opin Ther Targets,2007,11(4):527-540.
  • 8Potet F,Bouyssou T,Escande D,et al.Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-a-gogo K(+) channel[J].J Pharmacol Exp Ther,2001,299(3):1007-1012.
  • 9Kuryshev YA,Brown AM,Wang L,et al.Interactions of the 5-Hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels[J].J Pharmacol Exp Ther,2000,295(2):614-620.
  • 10刘清华 张杨 林媛媛 等.5-HT4受体激动剂兼5-HT3 受体阻断剂2-[1-(4-piperonyl)piperazinyl]-benzothiazole致心律失常机制探析.中国药理学通报,2010,26(4):461-465.

共引文献3

同被引文献44

  • 1荣培晶,朱兵.心经经脉与心脏相关联系的形态学研究[J].针刺研究,2005,30(2):97-101. 被引量:21
  • 2李柳骥,严季澜.冠心病心绞痛中医相关病名考辨[J].北京中医药大学学报(中医临床版),2007,14(2):32-35. 被引量:8
  • 3Yang GH, Wang Y,Zeng YX, et al. Rapid health transition in China,1990 -2010: findings from the Global Burden of disease Study 2010[J]. Uncet, 2013,381(9882) :I987.
  • 4Dumotier BM. A straightforward guide to the basic science behind ar-rhythmogenesis[ J]. Heart, 2014( 100) : 1907.
  • 5Schmitt N, Grunnet M, Olesen SP. Cardiac potassium channel sub-types :new roles in repolarization and arrhythmia [ J ]. Physiol Rev,2014,94(2) :609.
  • 6Anumonwo JM, Lopatin AN. Cardiac strong inward rectifier potassiumchannels[ J]. J Mol Cell Cardiol, 2010,48( 1 ) :45.
  • 7Khan E,Spiers C,Khan M. The heart and potassium: a banana repub-lic[ J]. Acute Card Care,2013 ,15(1) : 17.
  • 8Liang SH, Wang QY, Zhang WW, et al. Carbon monoxide inhibits in-ward rectifier potassium channels in cardiomyocytes[ J]. Nat Commun,2014,5:4676.
  • 9Kulzer M, Seyler C, Welke F, et al. Inhibition of cardiac Kir2. 1-2.3channels by beta3 adrenoreceptor antagonist SR 59230A [ J]. Bio-chem Biophys Res Commun, 2012,424(2) :315.
  • 10Gomez R, Caballero R, Barana A, et al. Structural basis of drugs thatincrease cardiac inward rectifier Kir2. 1 currents[ J] . Cardiovasc Res,2014,104(2) :337.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部